• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GSPE 干扰体内 tau 聚集:治疗 tau 病的意义。

GSPE interferes with tau aggregation in vivo: implication for treating tauopathy.

机构信息

Department of Neurology, Mount Sinai School of Medicine, New York, NY 10029, USA.

出版信息

Neurobiol Aging. 2012 Sep;33(9):2072-81. doi: 10.1016/j.neurobiolaging.2011.09.027. Epub 2011 Nov 4.

DOI:10.1016/j.neurobiolaging.2011.09.027
PMID:22054871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3472512/
Abstract

Tauopathies are characterized by progressive neurodegeneration caused by intracellular accumulation of hyperphosphorylated tau protein aggregates in the brain. The present study was designed to test whether a grape seed polyphenolic extract (GSPE) previously shown to inhibit tau protein aggregation in vitro could benefit tau-mediated neuropathology and behavior deficits in JNPL3 transgenic mice expressing a human tau protein containing the P301L mutation. Nine-month-old JNPL3 mice were treated with GSPE delivered through their drinking water for 6 months. We found that GSPE treatment significantly reduced the number of motor neurons immunoreactive for hyperphosphorylated and conformationally-modified tau in the ventral horns of the spinal cord identified using AT100, PHF-1, AT8, and Alz50 tau antibodies. This coincided with a drastically reduced level of hyperphosphorylated and sarcosyl-insoluble tau in spinal cord fractions. Furthermore, the reduction of tau pathology was accompanied by an improvement in the motor function assessed by a wire hang test. Collectively, our results suggest that GSPE can interfere with tau-mediated neurodegenerative mechanisms and ameliorate neurodegenerative phenotype in an animal model of tauopathy. Our studies support further evaluation of GSPE for preventing and/or treating of tauopathies in humans.

摘要

tau 病是以脑内过度磷酸化 tau 蛋白聚集导致进行性神经退行性变为特征的。本研究旨在测试先前已证明可抑制体外 tau 蛋白聚集的葡萄籽多酚提取物(GSPE)是否可有益于表达人 tau 蛋白 P301L 突变的 JNPL3 转基因小鼠的 tau 介导的神经病理学和行为缺陷。用含有 GSPE 的饮用水对 9 个月大的 JNPL3 小鼠进行 6 个月的处理。我们发现,GSPE 处理显著减少了使用 AT100、PHF-1、AT8 和 Alz50 tau 抗体鉴定的脊髓腹角中 AT100、PHF-1、AT8 和 Alz50 tau 抗体免疫反应性的磷酸化和构象修饰 tau 阳性的运动神经元的数量。这与脊髓分数中高度磷酸化和肌氨酸不可溶性 tau 的水平明显降低相一致。此外,tau 病理学的减少伴随着通过线悬挂试验评估的运动功能的改善。总的来说,我们的结果表明,GSPE 可以干扰 tau 介导的神经退行性机制,并改善 tau 病动物模型中的神经退行性表型。我们的研究支持进一步评估 GSPE 用于预防和/或治疗人类的 tau 病。

相似文献

1
GSPE interferes with tau aggregation in vivo: implication for treating tauopathy.GSPE 干扰体内 tau 聚集:治疗 tau 病的意义。
Neurobiol Aging. 2012 Sep;33(9):2072-81. doi: 10.1016/j.neurobiolaging.2011.09.027. Epub 2011 Nov 4.
2
Endogenous tau aggregates in oligodendrocytes of rTg4510 mice induced by human P301L tau.人源 P301L tau 诱导 rTg4510 小鼠少突胶质细胞内源性 tau 聚集。
J Alzheimers Dis. 2014;38(3):589-600. doi: 10.3233/JAD-130986.
3
Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates.tau蛋白酪氨酸磷酸化的增加与tau蛋白聚集体的形成相关。
Brain Res Mol Brain Res. 2005 Aug 18;138(2):135-44. doi: 10.1016/j.molbrainres.2005.04.015.
4
Ultrastructural alterations of Alzheimer's disease paired helical filaments by grape seed-derived polyphenols.葡萄籽油多酚对阿尔茨海默病双螺旋丝的超微结构改变。
Neurobiol Aging. 2012 Jul;33(7):1427-39. doi: 10.1016/j.neurobiolaging.2010.11.006. Epub 2010 Dec 31.
5
Accelerated neurodegeneration and neuroinflammation in transgenic mice expressing P301L tau mutant and tau-tubulin kinase 1.表达P301L tau突变体和tau-微管蛋白激酶1的转基因小鼠中加速的神经退行性变和神经炎症
Am J Pathol. 2014 Mar;184(3):808-18. doi: 10.1016/j.ajpath.2013.11.026. Epub 2014 Jan 10.
6
Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in mice.末端补体途径抑制剂缺乏促进小鼠神经元 tau 病理和变性。
J Neuroinflammation. 2012 Sep 18;9:220. doi: 10.1186/1742-2094-9-220.
7
Grape derived polyphenols attenuate tau neuropathology in a mouse model of Alzheimer's disease.葡萄来源的多酚可减轻阿尔茨海默病小鼠模型中的 Tau 神经病理学。
J Alzheimers Dis. 2010;22(2):653-61. doi: 10.3233/JAD-2010-101074.
8
Development of a grape seed polyphenolic extract with anti-oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathies.开发一种具有抗寡聚活性的葡萄籽多酚提取物,作为进行性核上性麻痹和其他tau蛋白病的新型治疗方法。
J Neurochem. 2010 Sep;114(6):1557-68. doi: 10.1111/j.1471-4159.2010.06875.x. Epub 2010 Jul 27.
9
Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy.自噬的刺激可减少人 tau 病小鼠模型中的神经退行性变。
Brain. 2012 Jul;135(Pt 7):2169-77. doi: 10.1093/brain/aws143. Epub 2012 Jun 10.
10
Early behavioural markers of disease in P301S tau transgenic mice.P301S tau 转基因小鼠疾病的早期行为标志物。
Behav Brain Res. 2010 Mar 17;208(1):250-7. doi: 10.1016/j.bbr.2009.12.002. Epub 2009 Dec 11.

引用本文的文献

1
Neurocognitive effects of proanthocyanidin in Alzheimer's disease: a systematic review of preclinical evidence.原花青素对阿尔茨海默病的神经认知影响:临床前证据的系统评价。
Braz J Med Biol Res. 2024 Nov 4;57:e13587. doi: 10.1590/1414-431X2024e13587. eCollection 2024.
2
Nerve growth factor receptor (Ngfr) induces neurogenic plasticity by suppressing reactive astroglial Lcn2/Slc22a17 signaling in Alzheimer's disease.神经生长因子受体(Ngfr)通过抑制阿尔茨海默病中反应性星形胶质细胞的Lcn2/Slc22a17信号传导来诱导神经源性可塑性。
NPJ Regen Med. 2023 Jul 10;8(1):33. doi: 10.1038/s41536-023-00311-5.
3
Gut Microbiota and its Metabolites: Bridge of Dietary Nutrients and Alzheimer's Disease.肠道微生物群及其代谢物:饮食营养素与阿尔茨海默病的桥梁。
Adv Nutr. 2023 Jul;14(4):819-839. doi: 10.1016/j.advnut.2023.04.005. Epub 2023 Apr 17.
4
Benefits of dietary polyphenols in Alzheimer's disease.膳食多酚在阿尔茨海默病中的益处。
Front Aging Neurosci. 2022 Dec 13;14:1019942. doi: 10.3389/fnagi.2022.1019942. eCollection 2022.
5
RNA methyltransferase NSun2 deficiency promotes neurodegeneration through epitranscriptomic regulation of tau phosphorylation.NSun2 介导的 RNA 甲基化酶缺陷通过转录组修饰调控 tau 磷酸化促进神经退行性变。
Acta Neuropathol. 2023 Jan;145(1):29-48. doi: 10.1007/s00401-022-02511-7. Epub 2022 Nov 10.
6
Unveiling the Potential of Polyphenols as Anti-Amyloid Molecules in Alzheimer's Disease.揭示多酚作为阿尔茨海默病抗淀粉样蛋白分子的潜力。
Curr Neuropharmacol. 2023;21(4):787-807. doi: 10.2174/1570159X20666221010113812.
7
Oral (-)-Epicatechin Inhibits Progressive Tau Pathology in rTg4510 Mice Independent of Direct Actions at GSK3β.口服(-)-表儿茶素可抑制rTg4510小鼠的tau蛋白病理进展,且与对糖原合酶激酶3β的直接作用无关。
Front Neurosci. 2021 Jun 16;15:697319. doi: 10.3389/fnins.2021.697319. eCollection 2021.
8
Development of grape polyphenols as multi-targeting strategies for Alzheimer's disease.开发葡萄多酚作为阿尔茨海默病的多靶点治疗策略。
Neurochem Int. 2021 Jul;147:105046. doi: 10.1016/j.neuint.2021.105046. Epub 2021 Apr 16.
9
Flavonoids as an Intervention for Alzheimer's Disease: Progress and Hurdles Towards Defining a Mechanism of Action.黄酮类化合物作为阿尔茨海默病的干预措施:确定作用机制的进展与障碍
Brain Plast. 2021 Feb 9;6(2):167-192. doi: 10.3233/BPL-200098.
10
A Ten-Day Grape Seed Procyanidin Treatment Prevents Certain Ageing Processes in Female Rats over the Long Term.连续十天用葡萄籽原花青素处理雌性大鼠可长期预防某些衰老过程。
Nutrients. 2020 Nov 27;12(12):3647. doi: 10.3390/nu12123647.

本文引用的文献

1
Ultrastructural alterations of Alzheimer's disease paired helical filaments by grape seed-derived polyphenols.葡萄籽油多酚对阿尔茨海默病双螺旋丝的超微结构改变。
Neurobiol Aging. 2012 Jul;33(7):1427-39. doi: 10.1016/j.neurobiolaging.2010.11.006. Epub 2010 Dec 31.
2
Grape derived polyphenols attenuate tau neuropathology in a mouse model of Alzheimer's disease.葡萄来源的多酚可减轻阿尔茨海默病小鼠模型中的 Tau 神经病理学。
J Alzheimers Dis. 2010;22(2):653-61. doi: 10.3233/JAD-2010-101074.
3
Tau-tubulin kinase 1 enhances prefibrillar tau aggregation and motor neuron degeneration in P301L FTDP-17 tau-mutant mice.Tau-微管蛋白激酶 1 增强 P301L FTDP-17 突变 tau 小鼠中的原纤维 tau 聚集和运动神经元变性。
FASEB J. 2010 Aug;24(8):2904-15. doi: 10.1096/fj.09-150144. Epub 2010 Mar 30.
4
Tau protein and tau aggregation inhibitors.tau 蛋白与 tau 聚集抑制剂。
Neuropharmacology. 2010 Sep-Oct;59(4-5):276-89. doi: 10.1016/j.neuropharm.2010.01.016. Epub 2010 Feb 10.
5
Neuropathology of non-Alzheimer degenerative disorders.非阿尔茨海默病性神经退行性疾病的神经病理学
Int J Clin Exp Pathol. 2009 Aug 25;3(1):1-23.
6
Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies.针对阿尔茨海默病及相关tau蛋白病的tau靶向药物研发进展。
Nat Rev Drug Discov. 2009 Oct;8(10):783-93. doi: 10.1038/nrd2959.
7
Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors.针对阿尔茨海默病和相关tau 病的 tau 定向药物发现:tau 组装抑制剂的重点。
Exp Neurol. 2010 Jun;223(2):304-10. doi: 10.1016/j.expneurol.2009.08.031. Epub 2009 Sep 8.
8
Biological and medicinal properties of grapes and their bioactive constituents: an update.葡萄及其生物活性成分的生物学和药用特性:最新进展
J Med Food. 2009 Jun;12(3):473-84. doi: 10.1089/jmf.2008.0096.
9
Identification of aminothienopyridazine inhibitors of tau assembly by quantitative high-throughput screening.通过定量高通量筛选鉴定tau蛋白组装的氨基噻吩并哒嗪抑制剂。
Biochemistry. 2009 Aug 18;48(32):7732-45. doi: 10.1021/bi9006435.
10
Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau.橄榄苦苷通过与tau蛋白的氨基反应抑制tau蛋白纤维化。
J Neurochem. 2009 Aug;110(4):1339-51. doi: 10.1111/j.1471-4159.2009.06224.x. Epub 2009 Jun 15.